Park Avenue Securities LLC grew its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 3.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 117,224 shares of the company’s stock after acquiring an additional 3,720 shares during the quarter. Park Avenue Securities LLC’s holdings in Procter & Gamble were worth $17,030,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter worth about $26,000. Montgomery Financial Services LLC bought a new position in shares of Procter & Gamble in the 2nd quarter valued at about $28,000. Paladin Partners LLC bought a new position in shares of Procter & Gamble in the 2nd quarter valued at about $29,000. Evergreen Advisors LLC purchased a new position in Procter & Gamble in the first quarter worth about $37,000. Finally, Toews Corp ADV purchased a new position in Procter & Gamble in the second quarter worth about $37,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Key Headlines Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Exchange-traded funds purchased approximately $82.8 million of PG stock on October 22, indicating institutional demand and potentially providing support for the shares. ETFs Bought $82.8 Million of Procter & Gamble
- Positive Sentiment: Several analysts remain constructive: JPMorgan raised its price target, while TD Cowen, BNP Paribas Exane and Citigroup reportedly forecast further appreciation. Freedom Broker also upgraded PG to Buy. JPMorgan Price Target Increase TD Cowen Forecast
- Positive Sentiment: Investment commentary highlights PG’s strong household-product market shares and appeal as a high-yield, defensive dividend stock—factors that may attract income-oriented investors. High-Yield Dividend Stock Comparison
- Neutral Sentiment: Articles comparing PG with Colgate-Palmolive and discussing TIPS, Treasury bills and dividend stocks reinforce PG’s defensive and income-investment appeal, but provide limited new company-specific information. PG Versus CL
- Negative Sentiment: Higher oil prices could raise manufacturing, packaging, transportation and other costs. Unless offset by pricing or productivity gains, this would pressure PG’s margins and earnings outlook. Impact of Higher Oil Prices
- Negative Sentiment: Insiders reported notable selling: Shailesh Jejurikar sold 35,000 shares worth about $5.7 million, while other executives sold shares as well. These transactions are not necessarily bearish, but the reductions in ownership can create a modest sentiment overhang. SEC Insider Filing
Insider Buying and Selling
In other news, CEO Shailesh Jejurikar sold 35,000 shares of the stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $163.09, for a total value of $5,708,150.00. Following the transaction, the chief executive officer directly owned 55,391 shares of the company’s stock, valued at approximately $9,033,718.19. This represents a 38.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Andre Schulten sold 3,914 shares of the business’s stock in a transaction on Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $568,860.76. Following the transaction, the chief financial officer owned 65,618 shares of the company’s stock, valued at $9,536,920.12. This represents a 5.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 58,647 shares of company stock valued at $9,268,508 over the last ninety days. Company insiders own 0.23% of the company’s stock.
Procter & Gamble Price Performance
PG opened at $159.96 on Tuesday. The company has a market capitalization of $370.75 billion, a price-to-earnings ratio of 24.09, a PEG ratio of 4.00 and a beta of 0.39. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25. The business’s fifty day simple moving average is $148.38 and its 200-day simple moving average is $148.47.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The company had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. During the same period in the prior year, the business earned $1.99 EPS. The firm’s quarterly revenue was up 4.0% on a year-over-year basis. On average, equities research analysts anticipate that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be issued a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.51%.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on PG shares. Freedom Broker raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $176.00 price objective on the stock in a research note on Friday. HSBC reaffirmed a “hold” rating and issued a $149.00 price objective (down from $182.00) on shares of Procter & Gamble in a research note on Thursday, July 30th. TD Cowen lifted their target price on Procter & Gamble from $150.00 to $166.00 and gave the stock a “hold” rating in a report on Friday. Sanford C. Bernstein reissued a “market perform” rating and set a $149.00 target price on shares of Procter & Gamble in a research report on Monday, August 24th. Finally, The Goldman Sachs Group restated a “neutral” rating and set a $161.00 price target on shares of Procter & Gamble in a report on Thursday. Fifteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $170.57.
Check Out Our Latest Research Report on PG
Procter & Gamble Company Profile
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
